Compare
Cardiff Lexington Corp vs SBC Medical Group Holdings Inc vs LifeMD, Inc. vs Hims & Hers Health, Inc.
| Latest fiscal year | Cardiff Lexington Corp CDIX | SBC Medical Group Holdings Inc SBC | LifeMD, Inc. LFMD | Hims & Hers Health, Inc. HIMS |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $11.54M | $173.61M | $194.06M | $2.35B |
| Revenue growth (YoY) | +39.5% | -15.5% | +25.3% | +59.0% |
| Gross margin | 62.5% | 73.3% | 85.7% | 73.8% |
| Operating margin | 9.5% | 38.9% | -4.0% | 4.5% |
| Net margin | -47.7% | 29.4% | 7.4% | 5.5% |
| Net income | -$5.51M | $50.99M | $14.35M | $128.37M |
| EPS (Diluted) | n/a | $0.50 | $0.25 | $0.51 |
| Operating cash flow | -$2.85M | $24.67M | $8.28M | $300.01M |
| Free cash flow | n/a | $23.27M | $6.41M | $57.41M |
| Cash & equivalents | n/a | $163.77M | n/a | $228.62M |
| Total assets | $29.09M | $380.45M | $70.41M | $2.15B |
| Total liabilities | $26.01M | $117.14M | $47.25M | $1.61B |
| Shareholders' equity | -$2.47M | $248.28M | $23.16M | $540.93M |
| Return on year-end equity | n/a | 20.5% | 62.0% | 23.7% |
| Shares outstanding | 13.70M | 102.58M | 46.66M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Cardiff Lexington Corp | SBC Medical Group Holdings Inc | LifeMD, Inc. | Hims & Hers Health, Inc. |
|---|---|---|---|---|
| Latest | $11.54M Ended 2025-12-31 | $173.61M Ended 2025-12-31 | $194.06M Ended 2025-12-31 | $2.35B Ended 2025-12-31 |
| 1 year earlier | $8.27M Ended 2024-12-31 | $205.42M Ended 2024-12-31 | $154.82M Ended 2024-12-31 | $1.48B Ended 2024-12-31 |
| 2 years earlier | $11.85M Ended 2023-12-31 | $193.54M Ended 2023-12-31 | $152.55M Ended 2023-12-31 | $872.00M Ended 2023-12-31 |
| 3 years earlier | $10.69M Ended 2022-12-31 | n/a | $119.03M Ended 2022-12-31 | $526.92M Ended 2022-12-31 |
| 4 years earlier | $9.88M Ended 2021-12-31 | n/a | $92.88M Ended 2021-12-31 | $271.88M Ended 2021-12-31 |